Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
Medicaid Coverage Increases for Pheburane for Urea Cycle Disorders.
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
- Additional Information
- Subject Terms:
- Abstract:
The article focuses on the inclusion of Pheburane (sodium phenylbutyrate) on the preferred drug lists of several state Medicaid programs and its coverage with preferred status at various pharmacy benefit managers (PBMs), indicating increasing accessibility for the treatment of urea cycle disorders (UCDs). It mentions Pheburane, developed to manage UCDs, has a special coating that masks the bitter taste of sodium phenylbutyrate, which has previously affected medication adherence.
No Comments.